FR2871696B1 - Composition topique pour le traitement du psoriasis - Google Patents

Composition topique pour le traitement du psoriasis

Info

Publication number
FR2871696B1
FR2871696B1 FR0406613A FR0406613A FR2871696B1 FR 2871696 B1 FR2871696 B1 FR 2871696B1 FR 0406613 A FR0406613 A FR 0406613A FR 0406613 A FR0406613 A FR 0406613A FR 2871696 B1 FR2871696 B1 FR 2871696B1
Authority
FR
France
Prior art keywords
psoriasis
treatment
topical composition
topical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0406613A
Other languages
English (en)
Other versions
FR2871696A1 (fr
Inventor
Leila Zarif
Claire Mallard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Priority to FR0406613A priority Critical patent/FR2871696B1/fr
Priority to US10/965,195 priority patent/US20050281755A1/en
Priority to MXPA06014409A priority patent/MXPA06014409A/es
Priority to BRPI0510840-3A priority patent/BRPI0510840A/pt
Priority to AU2005261571A priority patent/AU2005261571A1/en
Priority to CA002567687A priority patent/CA2567687A1/fr
Priority to CNA2005800199993A priority patent/CN1968681A/zh
Priority to JP2007515998A priority patent/JP2008502663A/ja
Priority to RU2007101540/15A priority patent/RU2007101540A/ru
Priority to PCT/FR2005/001496 priority patent/WO2006005844A1/fr
Priority to EP05777132A priority patent/EP1778185A1/fr
Priority to KR1020067026292A priority patent/KR20070024598A/ko
Publication of FR2871696A1 publication Critical patent/FR2871696A1/fr
Application granted granted Critical
Publication of FR2871696B1 publication Critical patent/FR2871696B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
FR0406613A 2004-06-17 2004-06-17 Composition topique pour le traitement du psoriasis Expired - Fee Related FR2871696B1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR0406613A FR2871696B1 (fr) 2004-06-17 2004-06-17 Composition topique pour le traitement du psoriasis
US10/965,195 US20050281755A1 (en) 2004-06-17 2004-10-15 Topical foam/mousse compositions for treating psoriasis
PCT/FR2005/001496 WO2006005844A1 (fr) 2004-06-17 2005-06-15 Composition moussante pressurisee pour le traitement topique du psoriasis
AU2005261571A AU2005261571A1 (en) 2004-06-17 2005-06-15 Pressurized foaming composition for topical treatment of psoriasis
CA002567687A CA2567687A1 (fr) 2004-06-17 2005-06-15 Composition moussante pressurisee pour le traitement topique du psoriasis
CNA2005800199993A CN1968681A (zh) 2004-06-17 2005-06-15 用于局部给药治疗牛皮癣的加压泡沫组合物
MXPA06014409A MXPA06014409A (es) 2004-06-17 2005-06-15 Composicion de espuma presurizada para tratamiento topico de psoriasis.
RU2007101540/15A RU2007101540A (ru) 2004-06-17 2005-06-15 Пенообразная композиция под давлением для топического лечения псориаза
BRPI0510840-3A BRPI0510840A (pt) 2004-06-17 2005-06-15 composição farmacêutica, composição pressurizada, bomba aerossol e uso de uma mistura de análogo de vitamina d e de um corticosteróide
EP05777132A EP1778185A1 (fr) 2004-06-17 2005-06-15 Composition moussante pressurisée pour le traitement topique du psoriasis
KR1020067026292A KR20070024598A (ko) 2004-06-17 2005-06-15 건선의 국소 치료용 가압화 발포성 조성물
JP2007515998A JP2008502663A (ja) 2004-06-17 2005-06-15 乾癬の局所治療用加圧型発泡性組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0406613A FR2871696B1 (fr) 2004-06-17 2004-06-17 Composition topique pour le traitement du psoriasis

Publications (2)

Publication Number Publication Date
FR2871696A1 FR2871696A1 (fr) 2005-12-23
FR2871696B1 true FR2871696B1 (fr) 2006-11-10

Family

ID=34949090

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0406613A Expired - Fee Related FR2871696B1 (fr) 2004-06-17 2004-06-17 Composition topique pour le traitement du psoriasis

Country Status (12)

Country Link
US (1) US20050281755A1 (fr)
EP (1) EP1778185A1 (fr)
JP (1) JP2008502663A (fr)
KR (1) KR20070024598A (fr)
CN (1) CN1968681A (fr)
AU (1) AU2005261571A1 (fr)
BR (1) BRPI0510840A (fr)
CA (1) CA2567687A1 (fr)
FR (1) FR2871696B1 (fr)
MX (1) MXPA06014409A (fr)
RU (1) RU2007101540A (fr)
WO (1) WO2006005844A1 (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8211449B2 (en) * 2004-06-24 2012-07-03 Dpt Laboratories, Ltd. Pharmaceutically elegant, topical anhydrous aerosol foam
AU2006313443A1 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
ES2447301T3 (es) * 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
CN101505725A (zh) * 2006-08-29 2009-08-12 特瓦制药工业有限公司 包含含维生素D的化合物和皮质类固醇化合物的具有低pH相容性的稳定的药理学活性组合物
GB2443161B (en) * 2006-10-28 2011-03-23 Nupharm Lab Ltd Clobetasol spray
GB2443162B (en) * 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US9532936B2 (en) 2007-03-08 2017-01-03 Strength Of Nature, Llc Compositions and methods for removing hair styling aids
EP1970048A1 (fr) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Composition topique de type polyaphron avec de la vitamine D
EP1970049A1 (fr) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Composition topique du type polyaphron avec de la vitamine D et un corticosteroide
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
EP2008651A1 (fr) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Patch bioérodable
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (fr) 2008-10-07 2010-04-15 Foamix Ltd. Support expansible à base d’huile et préparations
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
CA2712120A1 (fr) 2008-01-14 2009-07-23 Foamix Ltd. Compositions pharmaceutiques pouvant mousser de poloxamere avec des agents actifs et/ou des cellules therapeutiques, et utilisations
KR20110067145A (ko) * 2008-10-03 2011-06-21 넥스메드 홀딩스 인코포레이티드 건선 치료용 안정화된 조성물
US20120238535A1 (en) * 2009-02-23 2012-09-20 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
PT2400951T (pt) * 2009-02-25 2018-11-26 Mayne Pharma Llc Composições de espuma tópica
WO2010125470A2 (fr) 2009-04-28 2010-11-04 Foamix Ltd. Véhicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
CA2769625C (fr) 2009-07-29 2017-04-11 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses legeres, et leurs utilisations
WO2011013008A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes à base d'agents non tensioactifs non polymères, mousses légères, et leurs utilisations
CA2776474C (fr) 2009-10-02 2021-01-12 Foamix Ltd. Compositions de tetracycline a usage topique
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
JP5945268B2 (ja) * 2010-06-11 2016-07-05 レオ ファーマ アクティーゼルスカブ ビタミンｄ類似体およびコルチコステロイドを含むスプレー医薬組成物
AU2015203836B2 (en) * 2010-06-11 2016-09-01 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
CN103533962B (zh) 2011-03-14 2018-05-18 药品配送方案有限公司 一种眼用组合物
JP6371312B2 (ja) 2013-01-29 2018-08-08 アヴェクシン エーエス 坑炎症および抗腫瘍２−オキソチアゾール化合物ならびに２−オキソチオフェン化合物
JP6396230B2 (ja) * 2014-01-27 2018-09-26 株式会社ポーラファルマ 使用時泡状を呈する外用医薬組成物
JP6396229B2 (ja) * 2014-01-27 2018-09-26 株式会社ポーラファルマ 使用時泡状を呈する外用医薬組成物
GB201413695D0 (en) 2014-08-01 2014-09-17 Avexxin As Compound
FR3041538B1 (fr) * 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
GB201604318D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
US11351127B2 (en) 2016-09-21 2022-06-07 Avexxin As Pharmaceutical composition
EP3542788A1 (fr) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Composition topique comprenant calcipotriol et dipropionate de bétaméthasone

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
US5223244A (en) * 1988-06-20 1993-06-29 Shiseido Company, Ltd. Aerosol composition
EP0408756A4 (en) * 1988-12-07 1991-08-28 San-Ei Chemical Industries, Ltd. Method for preparing milk/mineral concentrate and mineralized drink
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
GB9300763D0 (en) * 1993-01-15 1993-03-03 Leo Pharm Prod Ltd Chemical compound
FR2701396B1 (fr) * 1993-02-12 1995-04-21 Oreal Procédé de stabilisation de vésicules de lipide(s) amphiphile(s) et composition pour application topique contenant lesdites vésicules stabilisées.
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
US6126949A (en) * 1998-04-06 2000-10-03 Bernel Chemical Company, Inc. Di-behenyl fumarate and its use in dermatological products
US6106874A (en) * 1998-11-18 2000-08-22 Abbott Laboratories Calcium fortified juice-based nutritional supplement and process of making
EP2915534B1 (fr) * 1999-04-23 2018-03-14 Leo Pharma A/S Composition pharmaceutique pour le traitement dermique du psoriasis comprenant une vitamine D et une corticostéroïde
US7074747B1 (en) * 1999-07-01 2006-07-11 Johnson & Johnson Consumer Companies, Inc. Cleansing compositions
PL212660B1 (pl) * 2000-10-27 2012-11-30 Leo Pharma As Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie
US20030059446A1 (en) * 2001-09-18 2003-03-27 Kulkarni Arun B. Physically stable sprayable gel composition
KR20050085787A (ko) * 2002-12-17 2005-08-29 갈데르마 소시에떼아노님 칼시트리올 및 클로베타솔 프로피오네이트의 배합물을함유하는 약학 조성물
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide

Also Published As

Publication number Publication date
AU2005261571A1 (en) 2006-01-19
CN1968681A (zh) 2007-05-23
WO2006005844A1 (fr) 2006-01-19
JP2008502663A (ja) 2008-01-31
US20050281755A1 (en) 2005-12-22
RU2007101540A (ru) 2008-07-27
MXPA06014409A (es) 2007-02-19
FR2871696A1 (fr) 2005-12-23
EP1778185A1 (fr) 2007-05-02
CA2567687A1 (fr) 2006-01-19
BRPI0510840A (pt) 2007-11-27
KR20070024598A (ko) 2007-03-02

Similar Documents

Publication Publication Date Title
FR2871696B1 (fr) Composition topique pour le traitement du psoriasis
DE602005014621D1 (de) 3-ä4-heterocyclyl-1,2,3-triazol-1-ylü-n-arylbenzamide als inhibitoren der cytokinenproduktion für die behandlung von chronischen entzündlichen erkrankungen
MA29098B1 (fr) Compositions pour le traitement du vhc
FR2915102B1 (fr) Utilisation d'un anticorps anti-cxcr4 pour le traitement du cancer
ITMI20020756A1 (it) Composizioni farmaceutiche topiche per il trattamento delle dermatiti
ATE478864T1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
FR13C0029I1 (fr) Compositions pour le traitement de troubles gastro-intestinaux
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
FR2887141B1 (fr) Orthese compressive tricotee du membre inferieur pour le traitement de l'insuffisance veineuse chronique
FR2902324B1 (fr) Utilisation d'acide ellagique pour le traitement de la canitie
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
PT2056814E (pt) Compostos de 2,5-di-hidroxibenzeno para o tratamento da psoríase
BRPI0915439A2 (pt) composição tópica para o tratamento de ceratose actínica
FR2897533B1 (fr) Agent oxydant pour le traitement des cheveux
DK1709082T3 (da) Sammensætning til behandling af patologi knyttet til MSRV/HERV-W
FR2893501B1 (fr) Compositions topiques pour favoriser l'homeostasie de la peau
DE602006006950D1 (de) Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis
DE602004026081D1 (de) Therapeutische humanisierte antikörper gegen cd45-isoformen
FR2906468B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
FR2917947B1 (fr) Composition phytosanitaire pour le traitement preventif et curatif du mildiou
DK1503747T3 (da) Diclofenacbaseret sammensætning til topisk behandling af sygdomme
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.
FR2910813B1 (fr) Nouvelle utilisation therapeutique pour le traitement des leucemies

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090228